RALPH LAUREN CORP (RL)       122.82  -1.39 (-1.12%)

122.82  -1.39 (-1.12%)

US7512121010 - Common Stock - After market: 122.82 0 (0%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RL. RL was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. RL has a medium financial health rating, its profitability is only medium as well. RL is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

4

RL has a Return On Assets of 7.66%. This is comparable to the industry average of 9.69%.
RL has a Return On Equity of 22.88%. This is comparable to the industry average of 23.41%.

RL has a Profit Margin of 8.05%. This is comparable to the industry average of 9.12%.
RL has a Piotroski-F score of 5.00. This indicates an average health and profitability for RL.
VS Industry

ROA (7.66%) VS Industry: 46% outperformed.

0.97
22.03

ROE (22.88%) VS Industry: 46% outperformed.

1.13
114.27

Profit Margin (8.05%) VS Industry: 46% outperformed.

1.63
19.11

Valuation

Valuation Rating

2

The Price/Earnings Ratio is 16.29, which indicates a correct valuation of RL.
The Forward Price/Earnings Ratio of 13.40 indicates a correct valuation of RL.
When comparing the current price to the book value of RL, we can conclude it is valued correctly. It is trading at 3.59 times its book value.
Compared to an average industry Enterprise Value to EBITDA ratio of 8.66, RL is valued in line with its industry peers.

Compared to an average industry Price/Earning Ratio of 11.65, RL is valued slightly more expensive.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates RL does not grow enough to justify the current Price/Earnings ratio.
When comparing the price book ratio of RL to the average industry price book ratio of 2.67, RL is valued more expensive than its industry peers.
VS Industry

Price/Earnings (16.29) VS Industry: 38% outperformed.

285.00
4.27

Price/Book (3.59) VS Industry: 34% outperformed.

13.05
0.43

Enterprise Value/ EBITDA (8.31) VS Industry: 52% outperformed.

1,138.33
3.01

Growth

Growth Rating

5

Based on estimates for the next 5 years, RL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.28% on average per year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue has grown by 14.44% in the past year. This is quite good.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

RL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 8.33%.
RL shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 7.87% yearly.
The Revenue has been decreasing by -1.34% on average over the past 5 years.
Based on estimates for the next 5 years, RL will show a small growth in Revenue. The Revenue will grow by 4.41% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS7.87% 5.07% 8.33% -4.56% 4.81% 9.8% 10.28%
Revenue-1.34% -0.5% 14.44% 1.48% 3.05% 3.83% 4.41%

Health

Health Rating

5

RL has a Current Ratio of 2.01. This indicates that RL is financially healthy and has no problem in meeting its short term obligations.
An Altman-Z score of 4.04 indicates that RL is not in any danger for bankruptcy at the moment.
When comparing the Altman-Z score to an average industry score of 3.15, RL is in better financial health than the average industry peer.
RL has a Quick Ratio of 1.27. This is a normal value and indicates that RL is financially healthy and should not expect problems in meeting its short term obligations.

RL has a Quick Ratio comparable to the industry average, which is at 1.14.
The Piotroski-F score of RL is 5.00. This is a neutral score and indicates average health and profitability for RL.
Compared to an average industry Current Ratio of 2.37, RL is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.44, RL is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.65) VS Industry: 36% outperformed.

5.42
0.00

Quick Ratio (1.27) VS Industry: 56% outperformed.

0.50
4.48

Current Ratio (2.01) VS Industry: 30% outperformed.

1.06
8.97

Altman-Z (4.04) VS Industry: 65% outperformed.

-1.98
13.94

Dividend

Dividend Rating

4

RL pays out 38.49% of its income as dividend. This is a sustainable payout ratio.
RL has been paying a dividend for at least 10 years, so it has a reliable track record.
RL has a Yearly Dividend Yield of 2.48%.

RL's Dividend Yield is comparable with the S&P500 average which is at 2.41.
RL's Dividend Yield is slightly below the industry average, which is at 2.96.
VS Industry

Dividend Yield (2.48%) VS Industry: 35% outperformed.

0.17
8.65

RALPH LAUREN CORP122.82

NYSE:RL (1/27/2023, 7:04:00 PM)-1.39 (-1.12%)

After market: 122.82 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Consumer Durables & Apparel
GICS Industry Textiles, Apparel & Luxury Goods
Earnings (Last) 11-10 2022-11-10/bmo Earnings (Next) 02-01 2023-02-01
Inst Owners 64.74% Inst Owner Change -0.04%
Ins Owners 2.39% Ins Owner Change 2.56%
Market Cap 8.11B Analysts 72.14
Price Target 118.4 (-3.6%)

Dividend
Dividend Yield 2.48% Dividend Growth N/A
DP 38.49% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 4.13%
Min EPS beat(2) 3.94% Max EPS beat(2) 4.33%
EPS beat(4) 4 Avg EPS beat(4) 17.89%
Min EPS beat(4) 3.94% Max EPS beat(4) 32.01%
Revenue beat(2) 1 Avg Revenue beat(2) 0.56%
Min Revenue beat(2) -1.69% Max Revenue beat(2) 2.8%
Revenue beat(4) 3 Avg Revenue beat(4) 2.38%
Min Revenue beat(4) -1.69% Max Revenue beat(4) 7.17%
PT rev (1m) 0.15% EPS NQ rev (1m) N/A
EPS NY rev (1m) 0% Revenue NQ rev (1m) N/A
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 16.29
Fwd PE 13.4
P/S 1.26
P/FCF 122.43
P/OCF 31.96
P/B 3.59
P/tB 6.26
EV/EBITDA 8.31
EPS(TTM) 7.54 EY 6.14%
EPS(NY) 9.16 Fwd EY 7.46%
FCF(TTM) 1 FCFY 0.82%
OCF(TTM) 3.84 OCFY 3.13%
SpS 97.11 BVpS 34.18
TBVpS 19.62 PEG (NY) N/A
PEG (5Y) 2.07

Profitability
Industry RankSector Rank
ROA 7.66%
ROE 22.88%
ROIC 11.42%
ROICexc 15.9%
ROICexgc 21.67%
OM 11.25%
PM 8.05%
GM 65.5%
ROICexgc(3y) 18.19% ROICexcg growth 3Y 0.72%
ROICexcg growth 5Y 13.32% ROICexc(3y) 12.13%
ROICexc growth 3Y 2.93% ROICexc growth 5Y 13.53%
OM growth 3Y 4.87% OM growth 5Y 13.03%
PM growth 3Y 12.24% PM growth 5Y N/A
GM growth 3Y 2.65% GM growth 5Y 3.98%
F-Score 5 Asset Turnover 0.95

Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 22.36
Debt/EBITDA 1.57
Cap/Depr 83.4%
Profit Quality 12.83%
Current Ratio 2.01
Quick Ratio 1.27
Altman-Z 4.04
F-Score 5 WACC 9.47%
ROIC/WACC 2.29 Cap/Depr(3y) 72.16%
Cap/Depr(5y) 68.3% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 8.33% EPS 3Y 5.07%
EPS 5Y 7.87% EPS growth Q2Q -14.89%
EPS Next Y -4.56% EPS Next 2Y 4.81%
EPS Next 3Y 9.8% EPS Next 5Y 10.28%
Revenue growth 1Y 14.44% Revenue growth 3Y -0.5%
Revenue growth 5Y -1.34% Revenue growth Q2Q 5.04%
Revenue Next Year 1.48% Revenue Next 2Y 3.05%
Revenue Next 3Y 3.83% Revenue Next 5Y 4.41%
EBIT growth 1Y 11.16% EBIT growth 3Y 4.35%
EBIT growth 5Y 11.51% EBIT Next Year 19.55%
EBIT Next 3Y 11.77% EBIT Next 5Y 11.02%
FCF growth 1Y -80.77% FCF growth 3Y -2.16%
FCF growth 5Y -3.86% OCF growth 1Y -52.84%
OCF growth 3Y -2.98% OCF growth 5Y -5.55%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA